PGNY - Company ID 0001551306
The table below shows Progyny, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Revenue | $328.50M | $318.40M | $313.35M | $332.87M | $324.04M | $298.43M |
| Cost of revenue | $245.43M | $241.52M | $240.51M | $253.90M | $248.24M | $235.00M |
| Gross profit | $83.07M | $76.88M | $72.83M | $78.97M | $75.80M | $63.43M |
| R&D | $2.80M | - | $2.60M | - | $1.50M | - |
Progyny, Inc. reported annual revenue of $1.29B for fiscal year 2025. That is up 10.4% from $1.17B in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $48.58M (FY 2017) to $1.29B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $30.81M | $43.67M | $33.37M | $36.21M | $33.84M | $32.03M |
| Operating income | $35.38M | $15.22M | $21.53M | $24.36M | $24.17M | $15.79M |
| Income tax | $12.65M | $5.37M | $10.10M | $9.96M | $11.48M | $7.13M |
| Net income | $24.23M | $12.48M | $13.86M | $17.11M | $15.06M | $10.53M |
| EPS (diluted) | $0.29 | $0.14 | $0.15 | $0.19 | $0.17 | $0.12 |